BioBladder – a national longitudinal sampling study providing a comprehensive framework to precision oncology in urothelial cancer

Fernanda Costa Svedman(Karolinska Institutet), Anders Ullén(Karolinska Institutet), Dimitrios Papantoniou, Alexandra Grahn(Karolinska University Hospital), Linda Willén(Gävle Hospital), Ayako Miyakawa(Karolinska Institutet), Ingrida Verbiené(Uppsala University Hospital), Oscar Laurin(Karolinska University Hospital), Emilie Flaberg(Karolinska Institutet), Sinja Taavitsainen(Tampere University of Applied Sciences), Per Hanberger(Linköping University Hospital), Faith Jawdat(Karolinska Institutet), Juhana Rautiola(Karolinska University Hospital), Karin Holmsten(Karolinska Institutet), Sara Renberg(Karolinska Institutet), Tony Ullman(KTH Royal Institute of Technology), Päivi Östling(Karolinska Institutet), Karin Söderkvist(Umeå University), Elin Jänes(Länssjukhuset Sundsvall-Härnösand), Johan Lindberg(Karolinska Institutet), Sigrid Isaksson, R. Sánchez-Salas(Karolinska University Hospital), Martin Bruzelius(County Hospital), Alexandra Grönn-Weiss(Karlstad Central Hospital), Ellen Heurlin(Karolinska Institutet), David Krantz(Karolinska Institutet), Rita Hutyra-Gram(Karolinska Institutet), Mikaela Hermansson Salmi(Karolinska Institutet), Olof Akre(Karolinska University Hospital), Elzbieta Wojtyna(Länssjukhuset i Kalmar), Tomas Thiel(Karolinska Institutet), Stefano Rapisarda(Karolinska Institutet), Charlotte Stadler(Karolinska University Hospital), Jenny Isaksson(Linköping University Hospital), Johan Björklund(Karolinska University Hospital)

Research Square

June 9, 2026

Cited by 0

Related Papers

|Cancer Discovery|2018|520

|Neurology|2007|161

|International Journal of Cancer|2010|99

|Clinical Cancer Research|2021|94

|European Urology|2020|90